Abstract
Drug discovery is mostly guided by innovative and knowledge by the application of experimental and computational approaches. Quantitative structure-activity relationships (QSAR) have a critical task in the discovery and optimization of lead compounds, thereby contributing to the development of new chemical entities. 3D-QSAR methods use the information of the tridimensional molecular structure of ligands and can be applied to elucidate the relationships between 3D molecular interactions and their measured biological property, therefore, providing a rational approach for the development of new potential compounds. The purpose of this review is to provide a perspective of the utility of 3DQSAR approaches in drug design, focusing on progress, challenges and future orientations. The essential steps involved to generate reliable and predictive CoMFA models are discussed. Moreover, we present an example of application of a CoMFA study to derive 3D-QSAR models for a series of oxadiazoles inhibitors of Schistosoma mansoni Thioredoxin Glutathione Reductase (SmTGR).
Keywords: 3D-QSAR, alignment, CoMFA, docking, drug design, pharmacophore.
Current Computer-Aided Drug Design
Title:3D-QSAR Approaches in Drug Design: Perspectives to Generate Reliable CoMFA Models
Volume: 10 Issue: 2
Author(s): Cleber Camilo Melo-Filho, Rodolpho Campos Braga and Carolina Horta Andrade
Affiliation:
Keywords: 3D-QSAR, alignment, CoMFA, docking, drug design, pharmacophore.
Abstract: Drug discovery is mostly guided by innovative and knowledge by the application of experimental and computational approaches. Quantitative structure-activity relationships (QSAR) have a critical task in the discovery and optimization of lead compounds, thereby contributing to the development of new chemical entities. 3D-QSAR methods use the information of the tridimensional molecular structure of ligands and can be applied to elucidate the relationships between 3D molecular interactions and their measured biological property, therefore, providing a rational approach for the development of new potential compounds. The purpose of this review is to provide a perspective of the utility of 3DQSAR approaches in drug design, focusing on progress, challenges and future orientations. The essential steps involved to generate reliable and predictive CoMFA models are discussed. Moreover, we present an example of application of a CoMFA study to derive 3D-QSAR models for a series of oxadiazoles inhibitors of Schistosoma mansoni Thioredoxin Glutathione Reductase (SmTGR).
Export Options
About this article
Cite this article as:
Melo-Filho Camilo Cleber, Braga Campos Rodolpho and Andrade Horta Carolina, 3D-QSAR Approaches in Drug Design: Perspectives to Generate Reliable CoMFA Models, Current Computer-Aided Drug Design 2014; 10 (2) . https://dx.doi.org/10.2174/1573409910666140410111043
DOI https://dx.doi.org/10.2174/1573409910666140410111043 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Advancement in the Diagnosis and Treatment of Leprosy
Current Topics in Medicinal Chemistry Meet the Editorial Board Member
Current Pharmaceutical Biotechnology Sunlight Vitamin D and Skin Cancer
Anti-Cancer Agents in Medicinal Chemistry Th2 Cytokines in Susceptibility to Tuberculosis
Current Molecular Medicine The Therapeutic Potential of Adenosine Triphosphate as an Immune Modulator in the Treatment of HIV/AIDS: A Combination Approach with HAART
Current HIV Research Imidazole and Pyrazole: Privileged Scaffolds for Anti-Infective Activity
Mini-Reviews in Organic Chemistry Epigenetic Control Using Natural Products and Synthetic Molecules
Current Medicinal Chemistry The Application of Cell-Penetrating-Peptides in Antibacterial Agents
Current Medicinal Chemistry Advances of Bioinformatics Applied to Development and Evaluation of Boron-Containing Compounds
Current Organic Chemistry Clinical and Pharmacological Aspects of Inflammatory Demyelinating Diseases in Childhood: An Update
Current Neuropharmacology Genotypic Characterization of Vancomycin-Resistant Enterococcus spp. In Tertiary Center, Iran
Infectious Disorders - Drug Targets Pulmonary Drug Delivery System: A Novel Approach for Drug Delivery
Current Drug Therapy Abiotic Regulation: A Common Way for Proteins to Modulate their Functions
Current Protein & Peptide Science Synthesis and Biological Activity of 2,7-Naphthyridine Derivatives: An Overview
Current Organic Chemistry Carbonic Anhydrases An Overview
Current Pharmaceutical Design Applications of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) in Pulmonary Disease
Current Respiratory Medicine Reviews Harnessing Polypharmacology with Computer-Aided Drug Design and Systems Biology
Current Pharmaceutical Design Targeting Host Factors to Circumvent Anti-Malarial Drug Resistance
Current Pharmaceutical Design Synthesis, Spectroscopic and Structural Studies of New 2-Substituted 4- Nitroimidazoles
Letters in Organic Chemistry Chemistry and Applications of 4-Hydroxyquinolin-2-one and Quinoline-2,4-dionebased Compounds
Current Organic Chemistry